Term
|
Definition
quinidine, lignocaine, propafenone, flecainide |
|
|
Term
|
Definition
class 1a
prolong ap duration
binds to na channels is use dependent manner
useful for: VENTRICULAR ARRHYTHMIAS, PAROXYSMAL RECURRANT ATRIAL FIBRILLATION. |
|
|
Term
|
Definition
CLASS 1B
decreased ap duration
supress automaticity
useful for: MYOCARDIAL INFARCTION, VENTRICULAR TACHYCARDIAS |
|
|
Term
|
Definition
minimal change in ap duration
supresses automaticity
increased refractory period
usefor: WPW SYNDROME, RECURRANT TACHYARRYTHMIAS
decreased cardiac contractility = contraindicated immediately post MI |
|
|
Term
|
Definition
|
|
Term
|
Definition
class II antiarrythmic agent
beta blocker
supress automaticity
shorter ap andf longer ref period
decreased conduction in both nodes
useful for: SVT, POST MI |
|
|
Term
|
Definition
class III antiarryhthmic agent = k channel blocker
prolonged ref period and ap
useful for: WPW SYNDROME, VENTRICULAR TACHYCARDIAS, ATRIAL FIBRILLATION |
|
|
Term
|
Definition
class IV antiarryhthmic agent = ca channel blocker
block av node
reduce o2 demand and cardiac work
useful for: PREVENTION OF PAROXYSMAL SVT, REDUCE VENTRICULAR RATE IN ATRIAL FIBRILLATION
|
|
|
Term
|
Definition
vagal stimulant
supress av conduction
decrease ventricular rate
useful for: SVT, ATRIAL FIB/FLUTTER |
|
|